Skip to content

Clinical Efficacy of Guishao Shengxue Decoction in the Treatment of Pediatric Immune Thrombocytopenia: A Randomized Controlled Trial

Clinical Efficacy of Guishao Shengxue Decoction in the Treatment of Pediatric Immune Thrombocytopenia: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000726
Enrollment
Unknown
Registered
2025-04-13
Start date
2024-01-11
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune thrombocytopenia

Interventions

control group:Placebo + conventional treatment
treatment group:Guishao Shengxue decoction + conventional treatment

Sponsors

The Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosed with persistent or chronic ITP through hematological examination. 2) Children aged 1 to 14 years. 3) Patients with chronic or persistent ITP. 4) Obtained informed consent from each enrolled patient or their legally authorized guardian.

Exclusion criteria

Exclusion criteria: 1) Secondary thrombocytopenia caused by other conditions. 2) Patients with other hematological disorders rheumatic diseases malignancies or severe infectious diseases. 3) Patients who had recently received other traditional Chinese medicine treatments or participated in other clinical trials. 4) Patients with severe cardiac hepatic or renal dysfunction. 5) Patients with known allergies or a history of hypersensitivity to any component of Guishao Shengxue Decoction. 6) Patients were unable to comply with study protocols or follow-up requirements.

Design outcomes

Primary

MeasureTime frame
clinical efficacy;mean platelet volume;plateletcrit;platelet distribution width;platelet count;

Secondary

MeasureTime frame
PAIgA;CD4/CD8 ratio;PAIgM;adverse events;hemoglobin;Baseline characteristics (sex, age, BMI, course of disease, platelet count);red blood cells;white blood cells;PAIgG;neutrophils;IL-6;CD8;CD3;CD4;

Countries

China

Contacts

Public Contactwangwei

The Affiliated Hospital of Changchun University of Traditional Chinese Medicine

99513742@qq.com13331666825

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026